Comments
Loading...

Halozyme Therapeutics Stock Price, Quotes and Forecasts

HALONASDAQ
Logo brought to you by Benzinga Data
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Halozyme Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:HALO | Benzinga

Explore Halozyme Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HALO.

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Dec 24
1
2
Jan
3
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$64.06
Close-
Volume / Avg.555.35K / 1.39M
Day Range$61.71 - $64.17
52 Wk Range37.73 - 66.00
Market Cap$7.64B
P/E Ratio18.60
Dividend Yield-
ExchangeNASDAQ
RSI
51
Short Interest
11.15%
Days to Cover6.92
About Halozyme Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO
ONC

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Halozyme Therapeutics (HALO) competitors?

Q

What is the forecast, or price target, for Halozyme Therapeutics (HALO) stock?

A

Halozyme Therapeutics has a consensus price target of $58.45.

Q

What is the current price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $61.825 last updated April 1, 2025 at 2:18 PM EDT.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch